339555-43-0

Basic information

• Product Name: 3(S)-(2-Methoxypyridin-5yl)-beta-alanine tert-butyl ester tosylate
• Synonyms: 3(S)-(2-Methoxypyridin-5yl)-beta-alanine tert-butyl ester tosylate
• CAS NO: 339555-43-0
• Molecular Formula: C20H28N2O6S
• Molecular Weight: 424.51112
• Mol File: 339555-43-0.mol
• Article Data: 3

Chemical Properties

• Melting Point: 142-144 °C
• Appearance: /
• CAS DataBase Reference: 3(S)-(2-Methoxypyridin-5yl)-beta-alanine tert-butyl ester tosylate(CAS DataBase Reference)
• NIST Chemistry Reference: 3(S)-(2-Methoxypyridin-5yl)-beta-alanine tert-butyl ester tosylate(339555-43-0)
• EPA Substance Registry System: 3(S)-(2-Methoxypyridin-5yl)-beta-alanine tert-butyl ester tosylate(339555-43-0)

Safety Data

• Hazardous Substances Data: 339555-43-0(Hazardous Substances Data)

Upstream product

• 67000-01-5 methyltertbutyl ether 
• 13472-85-0 2-methoxy-5-bromopyridine 
• 104-15-4 toluene-4-sulfonic acid 
• 339555-40-7 tert-butyl (3S)-3-{benzyl[(1R)-1-phenylethyl]amino}-3-(6-methoxypyridin-3-yl)propanoate 
• 1628-89-3 2-methoxypyridine 

Relevant articles and documents

COMPOSITION AND METHODS FOR TREATING CHRONIC KIDNEY DISEASE

This invention relates to the treatment of chronic kidney disease, including diabetic nephropathy, focal segmental glomerulosclerosis (FSGS), nephrotic syndrome, non-diabetic chronic kidney disease, renal fibrosis or acute kidney injury by the administrat

Alpha V integrin receptor antagonists

The present invention relates to novel imidazolidinone derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and/or